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Abstract: Objective: To identify structural white matter alterations in patients with pure hereditary
spastic paraplegia (HSP) using high angular resolution diffusion tensor imaging (DTI). Methods:
We examined 37 individuals with high resolution DTI, 20 patients with pure forms of hereditary
spastic paraplegia and 17 age and gender matched healthy controls. DTI was performed using a
3 T clinical scanner with whole brain tract-based spatial statistical (TBSS) analysis of the obtained
fractional anisotropy (FA) data as well as a region-of-interest (ROI)-based analysis of affected tracts
including the cervical spinal cord. We further conducted correlation analyses between DTI data
and clinical characteristics. Results: TBSS analysis in HSP patients showed significantly decreased
fractional anisotropy of the corpus callosum and the corticospinal tract compared to healthy controls.
ROI-based analysis confirmed significantly lower FA in HSP compared to controls in the internal
capsule (0.77 vs. 0.80, p = 0.048), the corpus callosum (0.84 vs. 0.87, p = 0.048) and the cervical spinal
cord (0.72 vs. 0.79, p = 0.003). FA values of the cervical spinal cord significantly correlated with
disease duration. Conclusion: DTI metrics of the corticospinal tract from the internal capsule to the
cervical spine suggest microstructural damage and axonal degeneration of motor neurons. The CST
at the level of the cervical spinal cord is thereby more severely affected than the intracranial part of the
CST, suggesting an ascending axonal degeneration of the CST. Since there is a significant correlation
with disease duration, FA may serve as a future progression marker for assessment of the disease
course in HSP.
Keywords: hereditary spastic paraplegia; diffusion tensor imaging; fractional anisotropy; tract-based
spatial statistics (TBSS); corticospinal tract
1. Introduction
Hereditary spastic paraplegias (HSP) are comprised of a group of inherited neurodegenerative
diseases characterized by a progressive weakness and spasticity of the lower limbs presumably caused
by a dysfunction of motor neurons [1,2]. “Pure” forms of HSP presenting with isolated spastic
paraparesis are distinguished from “complicated” forms with additional symptoms such as cerebellar
ataxia, epilepsy, peripheral neuropathy, visual and cognitive impairment [3]. HSPs are rare diseases
with an average prevalence of about 2–10/100,000 [4–6]. Until today, more than 80 genes and loci were
identified and a wide phenotypic variability has been described [7–9].
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Previous MRI studies in HSP revealed structural brain alterations like atrophy of the corpus
callosum and cortical or cerebellar atrophy as well as increased white matter signal intensities
particularly in patients with autosomal recessive complicated HSPs [10–13]. Using advanced imaging
techniques (diffusion tensor imaging, DTI), broad changes of white matter in HSP patients have been
revealed [14]. DTI analysis of HSP patients (SPG11, spastic paraplegia 11, classified as complicated
HSP) has shown even more widespread alterations and atrophy of grey and white matter compared to
conventional MR imaging in a small sample size [15,16]. One of the largest studies with 44 HSP patients
revealed alterations of association and motor as well as cerebellar white matter tracts irrespective of
genotype [14]. The changes in several non-motor regions led to the suggestion of a neurodegenerative
pathway involving extramotor regions as well [14]. Additionally, a study with a small sample size
found more severe changes in complicated HSP (SPG11) compared to pure HSP (SPG4) [17]. Important
imaging findings in patients with SPAST (SPG4) mutations described white matter changes mainly
in the corticospinal tract and the corpus callosum [18,19], in part additional grey matter atrophy [20].
Lindig et al demonstrated widespread affected grey and white matter including the corticospinal tract
(CST), the corpus callosum, medio-dorsal thalamus, parieto-occipital regions, upper brainstem and the
cerebellum in a cohort of 15 SPG4 patients [20].
Our aim was to identify microstructural alterations in relevant brain regions in patients with
pure HSP (pHSP) using diffusion tensor imaging. We excluded complicated forms of the disease to
avoid widespread changes of grey and white matter and performed reader independent, unbiased
tract-based spatial statistics (TBSS) analysis followed by a region-of-interest (ROI)-based measurement
of relevant brain regions.
More importantly, only a few previous studies analyzed the spinal cord of HSP patients, so far
focusing on the volume-loss of the spinal cord without gaining information about the integrity of the
CST [12,18,21]. As there is no specific tract-based analysis of the CST at the level of the cervical spinal
cord of pHSP patients available, we further performed a ROI-based analysis of the lateral funiculus.
As this method has not yet been performed in previous studies we aimed to quantify suspected
impairment specifically of the cervical CST and to obtain new information consistent with possible
pathophysiological theories.
2. Materials and Methods
2.1. Subjects
We recruited a total of 20 patients with pure hereditary spastic paraplegia (mean age 52.7± 9.7 years)
and 17 age and gender matched healthy controls (mean age 55.0 ± 8.9 years). The clinical diagnosis was
confirmed by an experienced movement disorder specialist according to the criteria of A. Harding [3]
and genetic testing revealed mutations in SPG4, SPG5 and SPG31 in 13 subjects. A genetical confirmation
of the disease in 7 patients was not possible. Patients underwent neurological examination and a full
medical history. We used the spastic paraplegia rating scale (SPRS) to assess disease severity. Detailed
clinical characteristics are shown in Table 1. The control subjects met the following inclusion criteria:
No neurologic disease, no gait impairment, normal brain imaging without any structural damage.
This study was approved by the Clinical Investigation Ethics Committee of the University of
Erlangen–Nuremberg. All subjects were informed in detail about the procedure and written informed
consent was obtained from all participants.
Brain Sci. 2019, 9, 268 3 of 14
Table 1. Demographic and clinical characteristics of hereditary spastic paraplegia (HSP) patients and
control subjects.
Clinical Information Patients with pHSP(n = 20)
Controls
(n = 17) p-Value
Age 52.7 ± 9.7 55.0 ± 8.9 0.45
Gender (female) 60.0% 64.7% 0.82
Disease onset (year) 32.0 ± 15.2
Disease duration (year) 20.7 ± 12.3
Genetic mutation:
SPG4
SPG5
SPG31
unknown
10 (50%)
2 (10%)
1 (5%)
7 (35%)
SPRS score
total 17.7 ± 7.2
subitem A 11.0 ± 4.4
subitem B 3.9 ± 1.8
subitem C 2.8 ± 2.0
pHSP = pure form of HSP, mean ± SD: data are means ± standard deviations, SPRS = spastic paraplegia rating scale
(52 points), Subitem A: Functional score (24 points), Subitem B: Spasticity and weakness (16 points), Subitem C:
Additional symptoms (12 points). p-values show group comparison using two-sample t-test or Mann-Whitney U
test depending on the normal contribution.
2.2. MR Imaging
We performed high resolution MR scans of the brain and the cervical spinal cord of all subjects
using a 3 Tesla scanner (Magnetom Tim Trio, Siemens Healthcare GmbH, Erlangen, Germany) with a
gradient field strength up to 45 mT/m (72 mT/m effective). DTI was performed in the axial plane with
2 mm slice thickness using a single-shot, spin echo, echo planar imaging (EPI) diffusion tensor sequence
(TR = 3400 ms, TE = 93 ms, FoV = 230 × 230 mm2, acquisition matrix size = 256 × 256 reconstructed
to 512 × 512). Diffusion weighting was carried out with a maximal b-factor of 1000 s/mm2 along 15
icosahedral directions complemented by one scan with b = 0.
2.3. Tract-Based Spatial Statistics
DICOM images were converted to NIfTI files (Neuroimaging Informatics Technology Initiative)
using dcm2nii from the MRIcron package (http://www.mccauslandcenter.sc.edu/micro/mricron/
dcm2nii.html). The resulting images were then preprocessed for TBSS analysis, i.e., corrected
for eddy currents with eddy_correct and brain extracted with bet2 [22]. We chose a bet2 threshold of
0.2 to remove all non-brain tissue. Next, a diffusion tensor model was fitted at each voxel to extract the
fractional anisotropy (FA) maps using DTIFIT. All of these preprocessing steps were carried out using
the FMRIB Diffusion Toolbox (FDT), which is part of FSL (http://fsl.fmrib.ox.ac.uk/fsl) [23]. We used the
JHU White-Matter Tractography Atlas for annotation [24,25]. For TBSS analysis, images were reviewed
carefully and faulty images with quality issues were sorted out. Images were nonlinearly registered
to the FMRIB58_FA standard template. An average mean FA map was created and the original FA
images were nonlinearly registered to this group mean. This approach has been used before in TBSS
analysis of patients with Alzheimer’s disease who had ventricular enlargement due to atrophy [26].
Axial diffusivity (AD) and mean diffusivity (MD) maps were calculated as well (Figure 1).
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Figure 1. Whole brain voxel-wise analysis of white matter changes in HSP using tract-based spatial
statistics (TBSS). TBSS of the brain of patients with pure HSP revealed reduced fractional anisotropy (FA,
blue), increased axial diffusivity (AD, yellow) and increased mean diffusivity (MD, red) in comparison
to controls. Displayed on mean FA template. Significant values (p < 0.05, cluster threshold correction
for multiple comparison) are shown in blue, yellow and red respectively.
2.4. Region of Interest (ROI)-Based Analysis
To assess the extent of altered brain regions found in the TBSS analysis we performed region of
interest based measurements. The analysis was carried out on a PACS workstation using syngo.via
(Siemens Healthcare GmbH, Erlangen, Germany). For each measurement, the obtained FA maps were
co-registered to an anatomical MPRAGE dataset. This procedure facilitated anatomical orientation in
the colored FA maps and guaranteed correct placement of ROIs. Measurements of diffusion indices
were carried out in the axial plane of the FA map on the slice the structure could be appreciated best.
Circular ROIs were placed with a defined size depending on the target structure (corpus callosum
splenium 20 mm2; rostrum 30 mm2; internal capsule 15–20 mm2; crus cerebri 10 mm2). The corpus
callosum was analyzed at the level of the lateral ventricles. Three ROIs (left, middle, right) were drawn
in the splenium and 3 ROIs in the rostrum of the corpus callosum. In the internal capsule, 3 ROIs were
placed per side (anterior and posterior limb, genu). The crus cerebri was measured at the level of the
mammillary bodies and the interpeduncular fossa (3 ROIs per side).
Further measurements were performed at the upper cervical spinal cord at level of the dens and
the center of the body of the second (C2) and third (C3) cervical vertebra. Similar to the analysis of the
brain regions, colored FA maps were used. Sagittal co-registered MPRAGE datasets were used for
identification of the correct area. Six ROIs of a total size of 7.5 mm2 each were drawn in the lateral
funiculus bilaterally at each level. FA of each ROI was sumed up in mean values of each region (corpus
callosum splenium and rostrum, internal capsule, cerebral crura, cervical spinal cord dens, second
vertebra and third vertebra) for statistical analysis. ROI placement is depicted in Figure 2.
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Figure 2. Regions of interest (ROIs) based analysis of the corpus callosum (A), capsula interna (B) and
the cervical spinal cord (C) of HSP patients. In detail: ROIs in the rostrum (D) and splenium (E) of
the corpus callosum, crus anterior, posterior and genu of the capsula interna (F) and the corticospinal
tract of the cervical cord (G) at the level of the dens and the corpus of the second and third vertebral
body (C).
2.5. Statistical Analysis
Statistical analysis was performed using IBM SPSS Statistics for Macintosh (Version 25.0.0.1, IBM
Corp. in Armonk, NY, United States). Kolmogorov-Smirnov test was performed to test for normal
distribution of FA data. Depending on the distribution, data is presented as mean and standard
deviation (SD).
Depending on the distribution two-samples t-tests or Mann-Whitney U tests were performed
for group comparison of clinical data between the patient and the control group and in subgroup
comparison between SPG4 and non-SPG4. Due to non-parametric data mean FA values between the
patient and control group were analyzed using Mann-Whitney U tests. Age-matched controls were
used due to an age-dependent change of white matter including the internal capsule and the corpus
callosum [27]. Correlation analysis was carried out between DTI metrics and clinical data (age, disease
duration and SPRS) using Pearson or Spearman correlation coefficients. TBSS data was corrected for
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multiple comparisons over space by controlling the family-wise error rate using threshold-free cluster
enhancement. The significance level was set at p < 0.05 for all statistical analysis.
3. Results
3.1. TBSS
The unbiased TBSS analysis of the brain of pHSP patients revealed broad white matter alterations
in multiple DTI indices including commissure, association and projection fibers compared to healthy
controls (corrected for multiple comparisons, p < 0.05) as shown in Figure 1. Clusters of voxels with
significantly reduced FA and increased AD and MD were detected in the corpus callosum and the
centrum semiovale. Radial Diffusivity (RD) between pHSP patients and healthy controls did not
differ significantly.
In detail, FA was reduced in white matter tracts including the corpus callosum, the corticospinal
tract (centrum semiovale, the internal capsule, the crura cerebri), the optic radiation, the frontal
lobe, parieto-occipital regions, the temporal lobe and the brainstem. FA of the cerebellum was not
significantly different between patients and controls. AD was increased in areas with FA reduction.
Highest values were detected in the subregions of the corpus callosum, the centrum semiovale,
the inferior fronto-occipital fasciculus as well as the internal capsule on the right side. Similar to the FA
results, AD of the cerebellum was not significantly different between patients and controls. MD was
significantly increased in the body and splenium of the corpus callosum, the centrum semiovale,
the right internal capsule and occipital regions. A subgroup comparison between the FA of SPG4
patients and non-SPG4 patients did not reveal any significant differences; therefore, no further analysis
was performed.
3.2. ROI-Based Analysis
The subsequent ROI-based approach confirmed the results of the voxel-per-voxel analysis. FA data
in the ROI-based analysis did not show a normal distribution; therefore, non-parametric comparison
of mean values was performed. FA was reduced in descriptive statistical analysis in the internal
capsule and the cerebral crura of the pHSP patients in comparison to the control group, but did not
reach the significance level of p < 0.05. In contrast, the internal capsule, the corpus callosum and the
cervical spinal cord showed significantly reduced FA compared to the controls. No further subgroup
comparison regarding SPG4 subtype was performed as there was no significant difference found in the
TBSS analysis between the SPG4 and the non-SPG4 patients. Age-matched controls were used due to
an age-dependent change of white matter [27]. The results of the ROI-based analysis of the corpus
callosum, the internal capsule, the cerebral crura and the cervical spinal cord are presented in Table 2.
Table 2. Fractional anisotropy (FA) in HSP patients and controls.
Anatomical Region Patients Controls p-Value
corpus callosum 0.84 ± 0.05 0.87 ± 0.05 0.048
corpus callosum splenium 0.86 ± 0.04 0.90 ± 0.04 0.017
corpus callosum rostrum 0.81 ± 0.06 0.85 ± 0.06 0.104
internal capsule 0.77 ± 0.06 0.80 ± 0.06 0.048
cerebral crura 0.80 ± 0.06 0.82 ± 0.06 0.209
cervical spinal cord 0.72 ± 0.07 0.79 ± 0.07 0.003
cervical spinal cord dens 0.71 ± 0.07 0.77 ± 0.09 0.045
cervical spinal cord second vertebra (body) 0.71 ± 0.10 0.79 ± 0.08 0.022
cervical spinal cord third vertebra (body) 0.72 ± 0.09 0.81 ± 0.08 0.003
Statistical analysis of the fractional anisotropy (FA) in hereditary spastic paraplegia (HSP) patients shows significant
decrease in the corpus callosum and cervical spinal cord in comparison to healthy controls. Data are means± standard
deviations, p-value calculated using Mann-Whitney U test, significant p-values (<0.05) in bold print.
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3.3. ROI-Based Analysis of the Internal Capsule
FA was significantly reduced in the internal capsule (patients vs. controls 0.77± 0.06 vs. 0.80± 0.06,
p = 0.048).
3.4. ROI-Based Analysis of the Corpus Callosum
Analyzing the FA values of the corpus callosum of pHSP patients revealed significant results
(patients vs. controls 0.84 ± 0.05 vs. 0.87 ± 0.05, p = 0.048) in comparison to the control group
(Figure 3A). While the differences of the FA values of the rostrum of the corpus callosum did not
reach the significance level of p < 0.05 (Figure 3C), the splenium of the corpus callosum showed a
significantly decreased FA value compared to controls (patients vs. controls 0.86 ± 0.04 vs. 0.90 ± 0.04,
p = 0.017) (Figure 3B).
Figure 3. Decreased FA in the corpus callosum of HSP patients (cross-hatched bars) compared to
controls (grey bars). HSP patients show significantly decreased FA values of the corpus callosum (A).
Significantly decreased FA in the splenium of the corpus callosum (B), while FA of the rostrum (C)
shows no significant difference. Error bars indicate 95% CI. Asterisk indicate p < 0.05.
3.5. ROI-Based Analysis of the Cervical Spinal Cord
The cervical spinal cord was analyzed at level of the dens and the center of the body of the second
and third cervical vertebra. At all levels, a significantly reduced FA was found in pHSP patients
compared to healthy controls (Figure 4). FA was reduced at the level of the dens (patients vs. controls
0.71 ± 0.07 vs. 0.77 ± 0.09, p = 0.045), the second vertebra (0.71 ± 0.10 vs. 0.79 ± 0.08, p = 0.022) and the
third vertebra (0.72 ± 0.09 vs. 0.81 ± 0.08, p = 0.003). Average FA of the cervical cord was also reduced
(0.72 ± 0.07 vs. 0.79 ± 0.07, p = 0.003).
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Figure 4. Decreased FA in the cervical spinal cord in HSP compared to controls. Error bars indicate 95%
CI. Asterisk indicate p < 0.05, double asterisks p < 0.01. Significantly lower FA values in the cervical
spinal cord (A) and at the level of the dens (B), the second vertebra (C) and the third vertebra (D).
3.6. Correlation Analysis between DTI Parameters and Clinical Data
Correlation analysis of FA values with clinical data revealed a significant negative correlation of
the FA value of the cervical spinal cord with disease duration of pHSP patients (Spearman r = −0.457,
p < 0.05) (Figure 5). No correlation was found between further clinical data, e.g., age and disease
severity (assessed by the spastic paraplegia rating scale) and DTI parameters. Correlation analysis was
performed using the FA values obtained by ROI measurements.
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Figure 5. Correlation between FA of the cervical cord and disease duration. FA of the cervical cord
correlates significantly with disease duration of pHSP patients (r = −0.457, p < 0.05).
4. Discussion
Diffusion tensor imaging represents an advanced imaging technique that has been shown to be
suitable for analyzing structural changes in rare motor neuron diseases [28]. We used this approach to
visualize and identify structural white matter alterations in pHSP patients. While conventional MR
imaging in these patients is useful for excluding other diseases, DTI can reveal structural damage of
white matter tracts [29]. Tract-based voxel-wise DTI analysis of pHSP patients using TBSS revealed
structural changes of the corticospinal tract in pHSP. As expected regarding the pathophysiology
of pHSP, FA reductions were present at most brain levels of the CST (centrum semiovale, internal
capsule and cerebral crura) overlapping with an increased AD and MD. Widespread FA decrease of the
CST was described by several recent studies [14,18,30] including Lindig et al [20] who demonstrated
alteration of white matter integrity of the CST of 15 SPG4 patients using TBSS. These findings are
consistent with the hypothesis of a dysfunction of upper motor neurons and the CST as predominant
cause of spasticity and weakness of the lower limbs [2].
Alterations of brain parenchyma diffusion indices were not limited to motor tracts. Moreover,
our results suggest a more widespread and diffuse microstructural damage of white matter tracts in
HSP. A broad impairment of white matter tracts including association, commissure and projection
fibers could be demonstrated. In addition to the CST, FA reductions were also found in primary
non-motor regions like the corpus callosum, the fornix, the corona radiata as well as in most association
fibers including the superior and inferior longitudinal fasciculi, the inferior fronto-occipital fasciculi
and the cingulum. These are expected findings in complicated HSPs as SPG11 showing additional
symptoms and indicate a clinically perceptible impairment beyond the motor system and match the
results of studies of SPG11 patients that revealed pathological changes and atrophy of grey and white
matter—especially of the corpus callosum [15,16,31,32]. The broad alterations in pure HSP found in
our study confirm findings of previous studies analyzing multiple genotypes of pure and complicated
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HSP (e.g., SPG3a, 4, 5, 7, 10, 11, 15, 31, 35) [14,33] and studies concentrating on SPG4 [18,20] showing a
widespread impairment of commissure, association and projection fibers dominated by the corpus
callosum and the CST as well. Aghakhanyan et al [30] demonstrated white matter involvement in
12 pHSP patients performing TBSS. They found widespread FA reduction in several brain regions
including the CST, the corpus callosum, inferior and superior longitudinal fasciculi and anterior
thalamic radiations.
The extent of the alteration of white matter fiber tracts beyond the motor system suggests that the
disease may not only be explained by pathological changes of the CST. The appearance of non-motor
symptoms such as depression, fatigue or pain in SPG4 patients described by Servelhere et al [34]
indicates neuronal damage beyond the CST. Even SPG4 patients that tend to be classified as pure HSP
sometimes show additional symptoms like ataxia, cognitive impairment and lower motor neuron
dysfunction [35], pointing to pathological changes of non-motor systems. A previous study [36]
addressing the cellular pathology of the disease, demonstrated that spastin, mutated in SPG4 HSP,
is widely expressed in neurons of the central nervous system and is not limited to CST neurons and
axons. Furthermore, tau pathology as an indicator for cytoskeletal dysfunction was not only found
in spinal cord motor neurons but in non-motor regions as well [36]. These cellular anomalies of the
neuroglia also suggest that the disease is not limited to the motor system [36].
The combination of the DTI indices fractional anisotropy, radial diffusivity, axial diffusivity and
mean diffusivity can help reveal pathophysiological features of the disease as they characterize different
patterns of microstructural change across brain tissues, in particular the differentiation between axonal
damage and changes in myelination of neuronal fibers. DTI metrics were not normally distributed in
the corpus callosum, the internal capsule, the cerebral crura and the cervical spinal cord suggesting a
disease specific degeneration pattern. FA reduction is generally regarded as surrogate parameter of
impaired microstructural integrity whereas AD increase indicates axonal damage and RD increase
demyelination of neuronal fibers [29,37–39]. In our study, reduced FA was detected in white matter
tracts beyond the CST. To a lesser extent, AD and MD were increased in the corpus callosum, parts
of the semioval center, the CST and several association fibers. No difference of RD could be found
between pHSP patients and healthy controls. The decrease of FA suggests a widespread alteration in
microstructural integrity of white matter tracts of HSP patients. Moreover, FA decrease combined with
AD and MD increase indicates axonal damage as predominant pathophysiological change. Axonal
degeneration is the most common explanation for the characteristic symptoms of HSP patients [40],
probably caused by several molecular degenerations, e.g., abnormal axonal transport, endosome
membrane trafficking, endoplasmic reticulum morphology, protein misfolding or mitochondrial
disturbance depending on the exact mutation [1,40]. These pathogenetic abnormalities may cause
a degeneration or abnormal development especially of the long spinal cord axons leading to lower
extremity spastic weakness as a main symptom of the disease [40].
The most severe alterations in FA were detected in the cervical spinal cord of pHSP patients.
Our analysis revealed significantly reduced FA at the level of the dens, the second and third cervical
vertebra. Only a few previous studies have analyzed the spinal cord of HSP patients so far and were
focusing merely on the volume-loss of the spinal cord [12,14,18,21]. Common result of these studies
was an atrophy of the spinal cord. However, specific analysis of the lateral funiculus as part of the
CST has not been performed. We focused on the lateral funiculus containing the lateral corticospinal
tract with a ROI-based approach to proof an involvement of the spinal CST. Postmortem studies of
HSP patients demonstrated axonal degeneration of the CST, predominantly in the spinal cord with
a maximum in the distal parts of the neuronal fibers [36,41,42]. The long axons of the CST seem to
be affected most as they are more vulnerable, therefore supporting the hypothesis of a “dying back”
axonopathy [1,41]. In our study, the cervical parts of the CST appeared to be more affected than the
intracranial parts matching the concept of an ascending degeneration of the CST [41].
The limitations of our study comprise the incapacity of clinical spine coils to carry out DTI
measurements beyond the level of the third body of the cervical spinal cord. Signal loss caudal of C3
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and respiratory movement artifacts hamper correct identification of the relevant structures. Therefore,
future studies performing DTI of the whole spinal cord are needed to confirm the concept of an
ascending degeneration by demonstrating a primary impairment of caudal parts of the CST in HSP
patients. Potentially, DTI of the spinal cord could provide useful information in early HSP about the
pathophysiology of the disease.
Our results indicate a retrograde axonal degeneration of the CST mainly affecting the distal parts
of the axons of pyramid neurons. Hereby the significant negative correlation of FA of the cervical spinal
cord with disease duration indicates that a longer disease duration is related to a reduced FA value.
This suggests that FA may serve as a suitable progression marker to monitor clinical and subclinical
structural changes. Further longitudinal studies and long term follow-ups will be necessary to confirm
this hypothesis.
5. Conclusions
DTI analysis of the corticospinal tract from the internal capsule to the cervical spine reveals
reduced FA in pure hereditary spastic paraplegia and indicates microstructural damage and axonal
degeneration of motor neurons. The CST at the level of the cervical spinal cord is thereby more severely
affected than the intracranial part of the CST, suggesting an ascending axonal degeneration of the
CST. The significant negative correlation of FA of the CST at the level of the cervical cord with disease
duration indicates that FA may serve as a future progression marker for assessment of the disease
course in HSP
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1. Hereditary spastic paraplegia (HSP)
2. High angular resolution diffusion tensor imaging (HARDI-DTI)
3. Tract-based spatial statistic (TBSS)
4. Fractional anisotropy (FA)
5. Corticospinal tract (CST)
6. Spastic paraplegia (SPG)
7. pure HSP (pHSP)
8. Region-of-interest (RO)
9. Spastic paraplegia rating scale (SPRS)
10. echo planar imaging (EPI)
11. NIfTI files (Neuroimaging Informatics Technology Initiative)
12. FMRIB Diffusion Toolbox (FDT)
13. standard deviation (SD)
14. interquartile range (IQR)
15. Axial diffusivity (AD)
16. Mean diffusivity (MD)
17. Radial diffusivity (RD)
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